Rapid response to prevent and treat B12/Co deficiency
Our differential enrichment data suggest a complex regulatory pattern, where upregulated genes may contribute to increased metabolic output, while downregulated genes reflect potential reductions in biosynthetic pathways and cellular regulatory mechanisms (Figure 3E)
This triple-action mechanism distinguishes it from existing approved agents such as semaglutide (GLP-1 only) or tirzepatide (GLP-1/GIP dual agonist)
Additional proposed mechanisms include improved myocardial energetics, reduced inflammation, and attenuation of cardiac remodeling, although the relative contribution of each pathway remains uncertain [33,34,35]
GHK-Cu is identifiable by its distinct deep blue color, both as a lyophilized powder and in solution a visual indicator that copper is properly complexed with the peptide